Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|September 10, 2021
Salivary Gland CancersVatche TchekmedyianJournal of Clinical Pharmacy and Therapeutics|November 3, 2021
A Case of Cefepime-Induced Immune ThrombocytopeniaRebecca Bystrom, Minkey Wungwattana, Vatche TchekmedyianAcademic Medicine : Journal of the Association of American Medical Colleges|April 20, 2017
The Effect of Rubric-Guided, Focused, Personalized Coaching Sessions and Video-Recorded Presentations on Teaching Skills Among Fourth-Year Medical Students: A Pilot StudyVatche Tchekmedyian, Helen M Shields, Stephen R Pelletier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic CarcinomaVatche Tchekmedyian, Eric J Sherman, Lara Dunn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell CarcinomaGlenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, et al.Cancer Discovery|December 15, 2020
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation TherapiesMahesh Saqcena, Luis Javier Leandro-Garcia, Jesper L V Maag, et al.Molecular Genetics and Metabolism|April 15, 2017
Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic comaAnne H O'Donnell-Luria, Alexander P Lin, Sai K Merugumala, et al.Thyroid : Official Journal of the American Thyroid Association|January 20, 2022
Enhancing Radioiodine Incorporation in <i>BRAF</i>-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical TrialVatche Tchekmedyian, Lara Dunn, Eric Sherman, et al.The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.Pageof 2